1.0CM Plushttps://cm-plus.co.jp/encmp_arakihttps://cm-plus.co.jp/en/author/cmp_araki/rich600338<blockquote class="wp-embedded-content" data-secret="IHD8oEnkzg"><a href="https://cm-plus.co.jp/en/news/other/2026_0928/">New Column Series – “GMP WATCH NEWS” — Now Up to Part 2</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://cm-plus.co.jp/en/news/other/2026_0928/embed/#?secret=IHD8oEnkzg" width="600" height="338" title="“New Column Series – “GMP WATCH NEWS” — Now Up to Part 2” — CM Plus" data-secret="IHD8oEnkzg" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> https://cm-plus.co.jp/en/wp-content/uploads/2026/06/GMPP_cat_Others_14_e548213f52.jpg928485Last updated: September 28, 2026 Originally published: September 01, 2026   Series Overview This ongoing series provides comprehensive insights into the evolving landscape of global Good Manufacturing Practice (GMP) and regulatory compliance. Designed for life science and pharmaceutical professionals, the series explores both foundational quality principles and the latest regulatory shifts from major health authorities such as the FDA and PIC/S. By covering critical, up-to-date topics—including Contamination Control Strategy (CCS), Data Integrity in cloud environments, emerging environmental regulations (PFAS), and advanced risk controls (Nitrosamines), these articles aim to help organizations proactively adapt their Quality Management Systems (QMS) and manufacturing operations to meet strict, modern regulatory expectations. New articles will continue to […]